Injectable, self-healing hyaluronic acid-based hydrogels for spinal cord injury repair

Int J Biol Macromol. 2024 Apr;263(Pt 2):130333. doi: 10.1016/j.ijbiomac.2024.130333. Epub 2024 Feb 24.

Abstract

The cystic cavity that develops following spinal cord injury is a major obstacle for repairing spinal cord injury (SCI). The injectable self-healing biomaterials treatment is a promising strategy to enhance tissue repair after traumatic spinal cord injury. Herein, a natural extracellular matrix (ECM) biopolymer hyaluronic acid-based hydrogel was developed based on multiple dynamic covalent bonds. The hydrogels exhibited excellent injectable and self-healing properties, could be effectively injected into the injury site, and filled the lesion cavity to accelerate the tissue repair of traumatic SCI. Moreover, the hydrogels were compatible with cells and various tissues and possessed proper stiffness matched with nervous tissue. Additionally, when implanted into the injured spinal cord site, the hyaluronic acid-based hydrogel promoted axonal regeneration and functional recovery by accelerating remyelination, axon regeneration, and angiogenesis. Overall, the injectable self-healing hyaluronic acid-based hydrogels are ideal biomaterials for treating traumatic SCI.

Keywords: Hyaluronic acid; Injectable and self-healing; Spinal cord injury.

MeSH terms

  • Axons / pathology
  • Biocompatible Materials / pharmacology
  • Humans
  • Hyaluronic Acid / chemistry
  • Hyaluronic Acid / pharmacology
  • Hydrogels / chemistry
  • Spinal Cord Injuries* / drug therapy
  • Spinal Cord Injuries* / pathology
  • Spinal Cord Regeneration*

Substances

  • Hyaluronic Acid
  • Hydrogels
  • Biocompatible Materials